Press release
Advancements In Anti Diabetic Drug Development Trend: A Crucial Influence on the Liraglutide And Semaglutide Market's Transformation in 2025
Liraglutide And Semaglutide Market Insights
In the last few years, the market for liraglutide and semaglutide has seen rapid expansion. The market is predicted to jump from $15.19 billion in 2024 to $16.98 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.8%. Factors propelling growth in the preceding period include a rise in diabetes cases, an influx of obesity-related conditions, an increase in clinical trials, higher investment levels in diabetes research and development, and a growing public demand for more accessible treatment methods._x000D_
_x000D_
The market size for liraglutide and semaglutide is anticipated to experience significant growth in the near future, augmenting to $26.24 billion in 2029 with a compound annual growth rate (CAGR) of 11.5%. The surge in the given period attributable to several factors like enhanced adoption of GLP-1 receptor agonists, a rise in healthcare spending, broadening of pharmaceutical firms' product lines, increased disposable income and an ageing population prone to diabetes. Noteworthy trends within the forecast period encompass the incorporation of digital health platforms, execution of tailored dosing schemes, progress in drug delivery technology, biosimilar versions development, and the use of artificial intelligence in therapeutic decision-making._x000D_
_x000D_
What Factors Are Propelling the Expansion of the Liraglutide And Semaglutide Market?_x000D_
The liraglutide and semaglutide markets are expected to grow due to the increasing prevalence of diabetes, a chronic condition marked by high blood sugar levels caused by insulin resistance and insufficient insulin production. Sedentary lifestyles, poor dietary habits, and genetic predispositions have led to this surge in diabetic cases. Liraglutide and semaglutide play a crucial role in controlling blood glucose levels and mitigating the risks associated with diabetes in these patients. For example, as per the National Health Service, a UK government agency, in 2023, over an additional half a million (549,000) individuals in England were found to be at risk of type 2 diabetes, pushing the total count of people with non-diabetic hyperglycemia or pre-diabetes, under a GP's care to 3,615,330. This signifies a substantial increase from 3,065,825 in 2022, demonstrating an approximate rise of 20%. Hence, the escalating count of diabetic patients bolsters the growth of the liraglutide and semaglutide markets._x000D_
_x000D_
Get Your Free Sample Now - Explore Exclusive Market Insights:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=18400&type=smp_x000D_
_x000D_
Which Leading Companies Are Shaping the Growth of the Liraglutide And Semaglutide Market?_x000D_
Major companies operating in the liraglutide and semaglutide market are Pfizer Inc., Merck & Co. Inc., Bristol-Myers Squibb, AstraZeneca, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Pharma Co. Ltd., Shionogi & Co. Ltd., Cadila Pharmaceuticals, Kyowa Kirin Co. Ltd., Dr. Reddy's Laboratories Ltd., Biocon, Glenmark Pharmaceuticals Ltd., Bachem, Zealand Pharma, Shenzhen JYMed Technology Co. Ltd., Incepta Pharmaceuticals Ltd._x000D_
_x000D_
What Are the Major Trends Shaping the Liraglutide And Semaglutide Market?_x000D_
Leading businesses in the liraglutide and semaglutide markets are endeavoring to produce anti-diabetic biosimilars with an aim to augment glucose control and mitigate cardiovascular hazards in individuals suffering from diabetes. These are cost-effective replicas of the original diabetic biologics, designed to replicate their health benefits. For illustration, Glenmark Pharmaceuticals Ltd., an Indian pharmaceutical company, in January 2024, for the first time in India, introduced a biosimilar of the esteemed anti-diabetic medicine, Liraglutide. This anti-diabetic drug is essentially a biosimilar of Liraglutide, intended to enhance glycemic management among adults with type 2 diabetes mellitus. This product launch reduces the cost of daily therapy thereby increasing its accessibility to individuals across the country. Being priced at around INR 100 for a standard 1.2 mg dose per day, it significantly diminishes the therapy costs by almost 70% and necessitates a prescription for procurement._x000D_
_x000D_
What Are the Key Segments of the Liraglutide And Semaglutide Market?_x000D_
The liraglutide and semaglutide market covered in this report is segmented -_x000D_
_x000D_
1) By Type: Pills, Liquid_x000D_
2) By Administration: Parenteral, Oral_x000D_
3) By Application: Type 2 Diabetes Mellitus, Obesity, Other Applications_x000D_
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_
_x000D_
Subsegments:_x000D_
1) By Pills: Oral Tablets (Liraglutide, Semaglutide), Extended-Release Oral Formulations_x000D_
2) By Liquid: Injectable Solutions (Liraglutide, Semaglutide), Pre-Filled Syringes, Vials For Injection_x000D_
_x000D_
_x000D_
Pre-Book Your Report Now For A Swift Delivery:_x000D_
https://www.thebusinessresearchcompany.com/report/liraglutide-and-semaglutide-global-market-report_x000D_
_x000D_
Which Region Dominates the Liraglutide And Semaglutide Market?_x000D_
North America was the largest region in the liraglutide and semaglutide market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liraglutide and semaglutide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
What Is Covered In The Liraglutide And Semaglutide Global Market Report?_x000D_
_x000D_
- Market Size Analysis: Analyze the Liraglutide And Semaglutide Market size by key regions, countries, product types, and applications._x000D_
- Market Segmentation Analysis: Identify various subsegments within the Liraglutide And Semaglutide Market for effective categorization._x000D_
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape._x000D_
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market._x000D_
- Market Contribution: Evaluate contributions of different segments to the overall Liraglutide And Semaglutide Market growth._x000D_
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers._x000D_
- Industry Challenges: Analyze challenges and risks affecting the Liraglutide And Semaglutide Market._x000D_
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market._x000D_
_x000D_
Unlock Exclusive Market Insights - Purchase Your Research Report Now!_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18400_x000D_
_x000D_
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advancements In Anti Diabetic Drug Development Trend: A Crucial Influence on the Liraglutide And Semaglutide Market's Transformation in 2025 here
News-ID: 3864835 • Views: …
More Releases from The Business Research Company
n-Butanol Market to Grow at 5% CAGR, Reaching $4.52 Billion by 2029
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
n-Butanol Market Outlook: How is the Market Expected to Grow by 2025?
The market size for n-butanol has been experiencing a consistent growth in the past few years. The market is projected to expand from $3.55 billion in 2024 to $3.72 billion in 2025, demonstrating a Compound Annual Growth Rate…
Acrylic Powder Coating Market is Anticipated to Expand upto $1.98 Billion in 202 …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Forecasted Market Growth Rate of the Acrylic Powder Coating Industry?
The market for acrylic powder coating has seen sustained growth over the past few years. Expectations are for it to expand from a value of $1.53 billion in 2024 to $1.6 billion in 2025, reflecting a 4.5% compound…
L-lactide Industry Expected to Reach $2.64 Billion by 2029 at 12.7% CAGR
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
L-lactide Market Value Projection: How Much Will the Market Size by 2025?
The market size for l-lactide has experienced quick expansion in the past few years. The value is projected to increase from $1.45 billion in 2024 to $1.63 billion in 2025, representing a compound annual growth rate (CAGR) of 12.6%.…
Graphene Market is Anticipated to Expand upto $3.41 Billion in 2029
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Forecasted Market Growth Rate of the Graphene Industry?
In the latest years, the size of the graphene market has seen a substantial expansion. It is projected that it will rise from $1.32 billion in 2024 to $1.6 billion in 2025, with a compound annual growth rate (CAGR) of…
More Releases for Liraglutide
Impact Of Diabetic Population Growth On The Liraglutide Market: Critical Driver …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Liraglutide Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for liraglutide has seen substantial growth in recent years. The market size, which is expected to be at $6.38 billion in 2024, is projected to inflate to $6.95 billion in 2025, with a Compound…
Rising Diabetes Prevalence Drives Growth in Liraglutide and Semaglutide Markets …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Liraglutide And Semaglutide Industry Market Size Be by 2025?
In recent times, the liraglutide and semaglutide market has seen quick and impressive growth. The growth is projected to continue, with the market size increasing from $15.19 billion in 2024 to an estimated $16.98 billion in 2025,…
Key Trend Reshaping the Liraglutide Market in 2025: Expansion Of Generic GLP-1 P …
What combination of drivers is leading to accelerated growth in the liraglutide market?
The increasing diabetic population is expected to propel the liraglutide market. Diabetes, particularly type 2, is on the rise due to factors like sedentary lifestyles, unhealthy diets, and obesity. Liraglutide, a drug that mimics the GLP-1 hormone to regulate blood sugar, plays a significant role in managing diabetes. In March 2023, the UK's NHS reported a rise in…
Key Trend Reshaping the Liraglutide Market in 2025: Expansion Of Generic GLP-1 P …
"What Are the Projections for the Size and Growth Rate of the Liraglutide Market?
The market for liraglutide has seen robust expansion in the past few years. The market is projected to escalate from $6.38 billion in 2024 to $6.95 billion in 2025, representing a compound annual growth rate (CAGR) of 9.0%. This surge during the historic period can be linked to the rising numbers of individuals being identified with type…
Liraglutide Market Analysis 2024: Trends, Growth Drivers, and Key Players
"Gain a competitive edge with up to 30% off in-depth market reports-uncover key trends, growth drivers, and forecasts today!
The new report published by The Business Research Company, titled Liraglutide Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the liraglutide…
Liraglutide Market Analysis 2019 and Industry Insights in the Future
QY Research always aims at offering their clients an in-depth analysis and the best research material of the various market. This new report on the global Liraglutide market is committed fulfilling the requirements of the clients by giving them thorough insights into the market. An exclusive data offered in this report is collected by research and industry experts.
Request a Sample of this report at
http://www.qyresearchglobal.com/goods-1906246.html
Key Manufacturers:
HEC…
